Skip to content

Search

Showing results for "early lung health"

Assessing the effect of meningitis prevention and treatment.

In high-income countries serious bacterial infections such as meningitis are uncommon, but their severity has led to prompt adoption of vaccines for...

The triple challenges associated with age-related comorbidities in Down syndrome

Major increases in the survival of people with Down syndrome during the last two generations have resulted in extended periods of adulthood requiring...

Inaugural Winner of the Deborah Lehmann Research Award

Congratulations goes to Celestine Aho, the inaugural winner of the $30,000 Deborah Lehmann Research Award.

Telethon Institute a key player in new national autism research

The Telethon Institute will play a key role in a ground breaking, multi-million dollar Autism research centre announced by Prime Minister Julia Gillard.

CIRCA DIEM

The CIRCA DIEM Study is a clinical research study being coordinated by the Developmental Chronobiology Team at The Kids Research Institute Australia, who are based in Perth, Western Australia and involving research teams from Australia and New Zealand.

Child maltreatment: variation in trends and policies in six developed countries

We explored trends in six developed countries in three types of indicators of child maltreatment for children younger than 11 years.

Revolutionising diabetes management for children and families

Imagine living with a condition that requires you to make approximately 180 health- related decisions every day for the rest of your life.

FeBRILe3: Safety Evaluation of Febrile Infant Guidelines Through Prospective Bayesian Monitoring

Despite evidence supporting earlier discharge of well-appearing febrile infants at low risk of serious bacterial infection (SBI), admissions for ≥48 hours remain common. Prospective safety monitoring may support broader guideline implementation.

Duration of protection after first dose of acellular pertussis vaccine in infants

Without a booster dose, the effectiveness of 3 doses waned more rapidly from 2 to 4 years of age than previously documented for children >6 years of age who...